1
Urinary Incontinence: The Quiet Disrupter of Quality of Life

This activity offers CE credit for:

  • Physicians (CME)

Credit Expiration Date: February 1, 2018

Faculty
Steven Swift, MD
Professor, Obstetrics & Gynecology
Medical University of South Carolina

Statement of Need
Urinary incontinence (UI) is an embarrassing condition that many patients hesitate to bring up with their OB/GYN or clinician. They may feel shame and/or they may believe there is no effective treatment for the condition.1 In a survey of US women, only 45% of respondents who had weekly urine leakage had seen a clinician about treatment.

From the healthcare provider perspective, clinicians who perform gynecologic services may be hesitant to bring up the subject with patients out of the misperception that they have no effective treatments to offer and fear of a visit extending beyond its allotted time and backing up the office schedule. The subject of UI may also not be "top of mind" with other items they want to discuss during the visit. In fact, UI is treatable and the American Urological Association states that "it is imperative the health care professional be adept at identifying patients who might benefit from treatment."2

Given the resistance from both patients and providers to discuss UI, it is important for clinicians to strive to create a culture in the office where nurses and intake assistants ask all patients if they are experiencing UI signs and symptoms, and flag patients' charts for the doctor to talk about it with them.

  1. ACOG, AUGS. Urinary Incontinence in Women (Joint statement of ACOG and AUGS). 2015. Available at: http://www.augs.org/p/cm/ld/fid=820.
  2. American Urological Association. Urinary Incontinence. Education for Medical Students. July 2016. Available at: www.auanet.org/education/urinary-incontinence.cfm.

Activity Goal
This program will inform clinicians about the importance of talking to their patients about urinary incontinence and identifying patients who may be suffering from UI but do not mention it to their care providers.

Learning Objectives
At the conclusion of this activity, participants will be better able to:

  • Recognize the scope and significance of urinary incontinence (UI) as a disease and how it affects the lives of patients who suffer from it
  • Review simple strategies for incorporating routine screening for UI into office intake procedures
  • Use simple history and physical examination techniques to identify and characterize UI in women

Target Audience
The target audience for this activity is all clinicians involved in women's health, especially healthcare professionals involved in OB/GYN, family practice, and internal medicine specialties.

Financial Support
This program is supported by an educational grant from Consortia Medical, LLC.

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of CME Outfitters, LLC, and Jespersen & Associates, LLC. CME Outfitters, LLC is accredited by the ACCME to provide continuing medical education for physicians.

CME Outfitters, LLC designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/JA045 (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of its CME/CE activities. Faculty must disclose to the participants any relationships with the commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Steven Swift, MD: Receives research support from Astellas, Legal consultant for Boston Scientific, Editor-in-Chief for the International Urogynecology Journal

Jeffrey Helfand, DO (peer reviewer): no relationships to disclose

Carrie Mansfield (planning committee): no relationships to disclose

Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, and Consortia Medical do not endorse the use of any product outside of the FDA-labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patients for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


1
1

2017 Jespersen & Associates, LLC. Questions or comments? Please contact us.